O
ZBH icon

Ossiam’s Zimmer Biomet ZBH Stock Holding History

Ossiam’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$650K Sell
7,550
-254
-3% -$22.3K 0.01% 475
2026
Q1 		$706K Sell
7,804
-190
-2% -$17.4K 0.01% 256
2025
Q4 		$719K Buy
7,994
+4,017
+101% +$381K 0.01% 251
2025
Q3 		$392K Sell
3,977
-560
-12% -$55.5K 0.01% 567
2025
Q2 		$414K Sell
4,537
-2,512
-36% -$243K ﹤0.01% 490
2025
Q1 		$798K Buy
7,049
+501
+8% +$53.6K 0.01% 372
2024
Q4 		$692K Buy
6,548
+396
+6% +$42.5K 0.01% 418
2024
Q3 		$664K Sell
6,152
-3,796
-38% -$414K 0.01% 418
2024
Q2 		$1.08M Buy
9,948
+494
+5% +$58.2K 0.02% 346
2024
Q1 		$1.25M Sell
9,454
-5,012
-35% -$626K 0.02% 337
2023
Q4 		$1.76M Sell
14,466
-3,718
-20% -$415K 0.03% 253
2023
Q3 		$2.04M Sell
18,184
-3,628
-17% -$461K 0.04% 203
2023
Q2 		$3.18M Buy
21,812
+4,229
+24% +$575K 0.06% 166
2023
Q1 		$2.27M Buy
17,583
+8,882
+102% +$1.12M 0.05% 193
2022
Q4 		$1.11M Sell
8,701
-1,477
-15% -$171K 0.03% 250
2022
Q3 		$1.06M Buy
10,178
+3,339
+49% +$366K 0.03% 246
2022
Q2 		$719K Buy
6,839
+2,595
+61% +$308K 0.02% 256
2022
Q1 		$543K Buy
+4,244
New +$512K 0.01% 303
2021
Q4 		– Sell
-6,650
Closed -$945K – 483
2021
Q3 		$945K Sell
6,650
-14,850
-69% -$2.18M 0.03% 236
2021
Q2 		$3.41M Buy
21,500
+20,995
+4,157% +$3.4M 0.09% 136
2021
Q1 		$78K Buy
+505
New +$78.2K ﹤0.01% 402
2020
Q2 		– Sell
-1,485
Closed -$146K – 494
2020
Q1 		$146K Sell
1,485
-2,138
-59% -$280K 0.01% 351
2019
Q4 		$526K Sell
3,623
-1,699
-32% -$235K 0.04% 225
2019
Q3 		$709K Buy
+5,322
New +$687K 0.05% 184
2019
Q1 		– Sell
-1,945
Closed -$196K – 332
2018
Q4 		$196K Buy
+1,945
New +$219K 0.03% 197

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Ossiam's ZBH Position: Q2 2026 in Review

Ossiam reduced its Zimmer Biomet (ZBH) stake by 3.3% in Q2 2026, selling an estimated $22.3K and leaving 7,550 shares worth $650K. The position accounts for 0.01% of the portfolio, ranked #475.

Ossiam first reported a position in ZBH in Q4 2018 and has held it in 25 quarters since. The position peaked at $3.41M in Q2 2021. 909 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Ossiam held 7,550 shares of Zimmer Biomet worth $650K as of Q2 2026.
  • Ossiam sold 254 Zimmer Biomet shares in Q2 2026, an estimated $22.3K.
  • Zimmer Biomet made up 0.01% of Ossiam's portfolio in Q2 2026, its #475 holding.
  • Ossiam first reported a position in Zimmer Biomet in Q4 2018 and has held it in 25 quarters since.
  • Ossiam's Zimmer Biomet position peaked at $3.41M in Q2 2021.
  • 909 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Ossiam's 13F filing for Q2 2026, filed 13 Aug 2026.